2019-nCoV Spike Protein (RBD, Fc Tag)
RBD蛋白產(chǎn)品信息
純度:> 95 % as determined by SDS-PAGE.
蛋白質序列:RVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFADDDDKAVPRDSGCKPCICTVPEVSSVFIFPPKPKDVLTITLTPKVTCVVVDISKDDPEVQFSWFVDDVEVHTAQTQPREEQFNSTFRSVSELPIMHQDWLNGKEFKCRVNSAAFPAPIEKTISKTKGRPKAPQVYTIPPPKEQMAKDKVSLTCMITDFFPEDITVEWQWNGQPAENYKNTQPIMDTDGSYFVYSKLNVQKSNWEAGNTFTCSVLHEGLHNHHTEKSLSHSPGK
內(nèi)毒素< 1.0 EU per μg protein as determined by the LAL method.
生物活性
Measured by its binding ability in a functional ELISA.
Immobilized human ACE2 protein (His tag) at 2μg/mL (100μL/well) can bind 2019-nCoV Spike Protein (RBD, mFc Tag),the EC50 of 2019-nCoV Spike Protein (RBD, mFc Tag) is 15-50ng/mL.
蛋白構建
A DNA sequence encoding the NCP-CoV(2019-nCoV) Spike Protein (RBD) was expressed with the Fc region of mouse IgG1 at the C-terminus.
表達宿主:HEK293 Cells
種屬:2019-nCoV
預測 N 端:Arg
分子量The recombinant NCP-CoV(2019-nCoV) Spike Protein (RBD, mFc Tag) consists of 457 amino acids and predicts a molecular mass of 51.5 kDa.
緩沖液 Lyophilized from sterile PBS, pH 7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
運輸方式
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
穩(wěn)定性 & 儲存條件
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
復溶
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
研究領域
參考文獻
Shen S, et al. (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.
Du L, et al. (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.
Xiao X, et al. (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.
相關推薦:
SARS-COV2 Spike protein RBD Subunit,His Tag
SARS-CoV-2 (2019-nCoV) Spike Protein (S1 Subunit, His Tag)
SARS-CoV-2 (2019-nCoV) Spike Protein (S1+S2 ECD, His tag)
重組全長S蛋白 SARS-COV2 Spike protein S full length,His Tag
SARS-COV2 Spike protein RBD-591 Subunit,His Tag
重組TEV蛋白酶 Recombinant TEV Protease
重組SUMO蛋白酶 Recombinant SUMO Protease
重組CRISPR-Cas9蛋白
重組CRISPR-Cas12a蛋白
AsCas12a(cpf1)-NLS
FnCas12a(cpf1)
AapCas12b
AacCas12b(C2c1)
重組CRISPR-Cas13a蛋白
Cas14a1核酸酶
轉鐵蛋白(牛來源)Transferrin for Cell Culture
重組人胰島素(rhInsulin) Recombinant Insulin
Chemicals for COVID-19 research
Apicidin (A6132) Bafilomycin A1
Captopril (C0261) Chloramphenicol (C2844)
Chloroquine (C2950) Dabrafenib (D0004)
Daunorubicin (D0182) Entacapone (E5575)
H-89 (H0003) Haloperidol (H0142)
Indomethacin (I5315) (+)-JQ-1 (J6400)
Lisinopril (L3374) Linezolid (L3453)
Metformin (M2076) Midostaurin/PKC412 (P4008)
Mycophenolic Acid (M9710) Pevonedistat/MLN-4924 (M4454)
Ponatinib (P577520) Ribavirin (R3205)
Rapamycin (R0161) Ruxolitinib/INCB018424 (I5210)
Sapanisertib/INK128 (I5440) Tigecycline (T3324)
Valproic acid (V0148) Verdinexor (V182685)